Plant-Based Microbeads in Focus: Are They a Potential Natural Substitute for Ozempic in Weight Loss?

In a groundbreaking development, scientists and biotech companies are creating edible microbeads that could revolutionise weight loss strategies. These microbeads, reminiscent of small tapioca or boba balls, are designed to work directly in the gut to block fat absorption in a non-invasive and gentle manner.

The microbeads are made from natural ingredients such as green tea polyphenols, vitamin E, and seaweed. They function similarly to orlistat, a weight-loss drug, but without causing serious side effects like liver and kidney damage. This makes them a potentially safer and more accessible alternative to surgery or pharmaceuticals for weight loss.

Israel's Lembas has developed a bioactive peptide to activate the body's GLP-1 hormone, a key player in regulating glucose levels and promoting weight loss. Brands like Supergut are using probiotic fibre and resistant starches to create GLP-1 boosters. Meanwhile, Chilean startup NotCo has teased a botanical-based GLP-1 Booster that can be added to any food to help reduce consumption.

The high-fat, microbead-eating rats in preliminary trials showed similar intestinal fat excretion as a group treated with orlistat, without the gastrointestinal side effects. Rats consuming microbeads had reduced adipose tissue and less liver damage compared to the others, and excreted more fat in their faeces.

The microbeads spontaneously form through a series of chemical bonds between the green tea polyphenols and vitamin E. To protect them from the acidic environment in the stomach, the researchers coat the spheres with a seaweed-derived polymer that expands in response to the acidic pH. Upon consumption, the green tea polyphenols and vitamin E compounds bind to and trap partially digested fats in the intestine.

Scientists at Sichuan University have also been working on edible microbeads, while researchers in Spain have discovered two plant extracts that could be used as weight-loss pills without side effects. A human clinical trial with 26 participants is currently underway, with preliminary data expected within the next year.

The company developing the Ozempic-targeting plant-based microbeads is Novo Nordisk. The production of the microbeads can be easily scaled up, making them a promising solution for long-term health issues like diabetes and heart disease by promoting weight loss. As research continues, these edible microbeads could offer a significant step forward in weight loss management.

Plant-Based Microbeads in Focus: Are They a Potential Natural Substitute for Ozempic in Weight Loss?